AMIX AUTONOMIX MED INC revenue, earnings and financials
For the quarter ended June 30, 2026, AUTONOMIX MED INC reported revenue of $0, net income of −$2.73M and diluted EPS of n/a; over the last four quarters revenue was $0 and net income −$16.1M; for the fiscal year ended March 2026 revenue was $0.
AMIX annual revenue and earnings
- Fiscal year ended Mar 2026: revenue $0, gross profit n/a, operating income −$17.0M, net income −$16.7M (margin n/a), EPS n/a
- Fiscal year ended Mar 2025: revenue $0, gross profit n/a, operating income −$11.6M, net income −$11.4M (margin n/a), EPS n/a
- Fiscal year ended Mar 2024: revenue $0, gross profit n/a, operating income −$12.0M, net income −$15.4M (margin n/a), EPS n/a
- Fiscal year ended Mar 2023: revenue $0, gross profit n/a, operating income −$1.99M, net income −$1.99M (margin n/a), EPS n/a
AMIX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$2.73M, EPS n/a
- Quarter ended Mar 31, 2026 (from the annual report): revenue $0, net income −$2.67M, EPS n/a
- Quarter ended Dec 31, 2025: revenue $0, net income −$3.26M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $0, net income −$7.45M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $0, net income −$3.34M, EPS n/a
- Quarter ended Mar 31, 2025 (from the annual report): revenue $0, net income −$11.4M, EPS n/a
- Quarter ended Dec 31, 2024: revenue $0, net income −$2.71M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $0, net income −$2.81M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $0, net income −$2.70M, EPS n/a
- Quarter ended Mar 31, 2024 (from the annual report): revenue $0, net income −$15.4M, EPS n/a
- Quarter ended Dec 31, 2023: revenue $0, net income −$3.11M, EPS −$0.23
- Quarter ended Sep 30, 2023: revenue $0, net income −$6.04M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $0, net income −$865K, EPS n/a
- Quarter ended Mar 31, 2023 (from the annual report): revenue n/a, net income −$657K, EPS n/a
- Quarter ended Dec 31, 2022: revenue n/a, net income −$544K, EPS −$0.05
- Quarter ended Sep 30, 2022: revenue n/a, net income −$448K, EPS n/a
- Quarter ended Jun 30, 2022: revenue n/a, net income −$341K, EPS n/a
AMIX cash flow, buybacks and dividends
- Fiscal year ended Mar 2026: operating cash flow −$12.3M, share buybacks n/a
- Fiscal year ended Mar 2025: operating cash flow −$8.26M, share buybacks n/a
- Fiscal year ended Mar 2024: operating cash flow −$6.60M, share buybacks n/a
- Fiscal year ended Mar 2023: operating cash flow −$1.85M, share buybacks n/a
AMIX balance sheet
- Jun 30, 2026: cash $3.46M, total assets $3.98M, total liabilities $818K, shareholders' equity $3.16M
- Mar 31, 2026: cash $7.00M, total assets $7.60M, total liabilities $1.71M, shareholders' equity $5.90M
- Dec 31, 2025: cash $9.93M, total assets $10.2M, total liabilities $1.65M, shareholders' equity $8.56M
- Sep 30, 2025: cash $7.48M, total assets $7.93M, total liabilities $1.49M, shareholders' equity $6.45M
- Jun 30, 2025: cash $8.59M, total assets $9.00M, total liabilities $1.97M, shareholders' equity $7.03M
- Mar 31, 2025: cash $9.14M, total assets $9.81M, total liabilities $1.71M, shareholders' equity $8.10M
- Dec 31, 2024: cash $11.8M, total assets $12.0M, total liabilities $2.25M, shareholders' equity $9.71M
- Sep 30, 2024: cash $5.16M, total assets $5.37M, total liabilities $2.34M, shareholders' equity $3.03M
What is AMIX's revenue?
AUTONOMIX MED INC reported $0 of revenue over its last four quarters, through June 30, 2026.
Is AMIX profitable?
No. AUTONOMIX MED INC lost $16.1M over the last four quarters.